ReviewActa Cardiologica Sinica2021
Visfatin as a Promising Marker of Cardiometabolic Risk.
Mehmet ErtenPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it
ReviewActa Cardiologica Sinica2021
Mehmet ErtenPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.